How high dose vitamin C kills cancer cells
Natural health experts have long maintained that vitamin C can fight cancer – if given in sufficiently large doses. But it is sometimes difficult to achieve the high blood concentration that is necessary for it to be effective.
Now, a new form of vitamin C is correcting that frustrating problem – and proving to be a game-changer. Liposomal vitamin C has been found to create blood levels that are 100 to 500 times higher than levels seen with conventional oral ingestion, setting the stage for the vitamin to aggressively combat cancer.
Cell and animal studies show impressive results with vitamin C
Recent research conducted at the University of Iowa confirms that vitamin C selectively kills cancer cells – while leaving normal cells undamaged. In one study, vitamin C reduced cancer-causing mutations in mice; in another, it was found to kill up to 50 percent of human lymphoma cells.
In a joint study conducted by leading medical institutions that included Harvard Medical School and Tufts Medical Center, researchers found that high-dose vitamin C impaired the growth of two different types of mutant colorectal cancer cells – in both test tubes and animals.
Problem solved: Past studies used insufficient dosages
In the past, researchers at the National Institutes of Health and at the Mayo Clinic dismissed vitamin C as a potential cancer treatment, maintaining that it is impossible to achieve cancer-killing concentrations of vitamin C in the blood through oral administration. In many studies, however, researchers simply failed to give sufficiently large amounts of vitamin C – leading to ‘inconclusive results.’
There was one notable exception to this pessimistic view of vitamin C’s abilities. In a 2008 review published in Puerto Rico Health Sciences Journal, the researchers examined the results of studies that used extremely high doses of intravenous vitamin C – and came to a different conclusion.
The authors noted that the efficacy of vitamin C therapy could not be judged when oral doses were given — but stated that vitamin C “may indeed be effective against tumors when administered intravenously.”
One would expect such an encouraging finding – involving a cheap, safe and natural way to treat cancer – to be trumpeted from the rooftops. Yet, this was not the case.
Although the authors urgently called for a re-examination of vitamin C’s ability to treat cancer, the article received little notice, and at one point was out of print or otherwise unavailable to the public – leading some vitamin C advocates to speculate that it was being deliberately suppressed.